Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-24-002748
Filing Date
2024-08-23
Accepted
2024-08-23 16:08:08
Documents
6

Document Format Files

Seq Description Document Type Size
1 F-3 zk2431902.htm F-3 448511
2 EXHIBIT 5.2 exhibit_5-1.htm EX-5.1 11591
3 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 2608
4 EXHIBIT 107 exhibit_107.htm EX-FILING FEES 29691
5 image0.jpg GRAPHIC 224359
6 image00001.jpg GRAPHIC 447436
  Complete submission text file 0001178913-24-002748.txt   1418910
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-281750 | Film No.: 241236366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)